Your browser doesn't support javascript.
loading
Exploring metabolic reprogramming in melanoma via acquired resistance to the oxidative phosphorylation inhibitor phenformin.
Pistoni, Mariaelena; Tondelli, Giulia; Gallo, Cristina; Torricelli, Federica; Maresca, Alessandra; Carelli, Valerio; Ciarrocchi, Alessia; Dallaglio, Katiuscia.
Afiliación
  • Pistoni M; Laboratory of Translational Research, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia.
  • Tondelli G; Laboratory of Translational Research, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia.
  • Gallo C; Laboratory of Translational Research, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia.
  • Torricelli F; Laboratory of Translational Research, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia.
  • Maresca A; IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital.
  • Carelli V; IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital.
  • Ciarrocchi A; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.
  • Dallaglio K; Laboratory of Translational Research, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia.
Melanoma Res ; 30(1): 1-13, 2020 02.
Article en En | MEDLINE | ID: mdl-31116160
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenformina / Reprogramación Celular / Hipoglucemiantes / Melanoma Límite: Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fenformina / Reprogramación Celular / Hipoglucemiantes / Melanoma Límite: Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article